In a rare day for biotech IPOs, Kythera Biopharmaceuticals ($KYTH) and Intercept Pharmaceuticals ($ICPT) hit the public markets Thursday with prices at the high end ...
Bluebird Bio and Intercept Pharma have reached separate agreements with regulators on the designs of key clinical trials for their respective blood disorder and fatty liver disease drugs. Bluebird Bio ...
The U.S. FDA’s release of its briefing document for the upcoming advisory committee meeting on obeticholic acid 25 mg as a fatty liver disease treatment sent Intercept Pharmaceuticals Inc. on a ...
The U.S. FDA’s release of its briefing document for the upcoming advisory committee meeting on obeticholic acid 25 mg as a fatty liver disease treatment sent Intercept Pharmaceuticals Inc. on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results